放射治疗引起的异口症的氨酸口水:一项随机临床试验
Cosimo Rupe1, Alessia Basco1, Gioele Gioco2
1Head and Neck Department, School of Dentistry, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Università Cattolica del Sacro Cuore, Largo A. Gemelli, 8, 00168, Rome, Italy.
概括
在头癌患者中,氨酸口水有效降低了放射治疗诱导的异口症 (RIX) 症状. 这种治疗改善了生活质量和患者满意度,没有任何不良事件.
科学领域:
- 在瘤学瘤学.
- 临床药房 临床药房
- 口腔医学是指口腔医学.
背景情况:
- 放射疗法诱导的异口症 (RIX) 是头癌 (HNC) 患者常见的,令人衰弱的副作用.
- 瑞克斯对幸存者的生活质量产生了重大影响.
研究的目的:
- 评估氨酸口水在缓解异口症症状方面的有效性.
- 评估治疗后生活质量和患者满意度的改善.
- 在RIX管理中,将氨酸口水与安慰剂进行比较.
主要方法:
- 一个双盲,随机临床试验 (RCT) 与一个交叉设计.
- 在罗马的Fondazione Policlinico Universitario A. Gemelli进行.
- 使用修改后的 Xerostomia 问卷 (XQ) 和利克尔特等级来进行评估.
主要成果:
- 与安慰剂 (p=0.01) 相比,氨酸口水显著降低了异口症症状 (p=0.01).
- 患者报告说,用氨酸口水 (p=0.001) 获得更高的满意度和更好的生活质量 (p=0.001).
- 在研究期间没有报告任何不良事件.
结论:
- -氨酸口水是RIX.的临床有效干预措施.
- 口水为HNC患者的RIX症状管理提供了安全和有益的选择.
- 这项研究支持使用氨酸来改善HNC幸存者的生活质量.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
217
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
217
Salivary Glands and Saliva
723
The salivary glands, of which there are three pairs known as the parotid, submandibular, and sublingual glands, play a crucial role in maintaining oral health and initiating the digestive process. Positioned near the ears, beneath the masseter muscle, the parotid glands secrete saliva into the oral cavity through the parotid duct of Stensen. Meanwhile, the submandibular glands, located on the floor of the mouth, secrete saliva through channels named submandibular ducts. The sublingual glands,...
723
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
170
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
170


